4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-24-005571
CHIEF MEDICAL OFFICER sold 511 shares at $19.50 ($9,965)
- CHIEF MEDICAL OFFICER acquired 511 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gillies Hunter · CHIEF MEDICAL OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-23 | Exercise or conversion : show line 1 in the form 10b5-1 | +511 | $1.74 | $889 | 3,762 | D |
| 2024-02-23 | Sale : show line 2 in the form 10b5-1 | −511 | $19.50 | $9,965 | 3,251 | D |
| Open-market sales · 511 sh · avg $19.50 · $9,965 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-23 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −511 | 3,014 | D |
Loading xslF345X05/form4-02272024_060201.xml…